Lyra Therapeutics LYRA Growth Metrics (2020-2025)

LYRA
$0.20 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT
Reported Financials

Lyra Therapeutics Quarterly Growth Metrics

Periods 23 quarters
Latest Dec 2025

Lyra Therapeutics growth metrics data for the quarter ended Dec 2025. These growth metrics cover 23 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y)
7.22M-13.05M-0.17M-0.09M0.09M12.42M-0.02M-0.45M-0.33M0.58M-0.04M0.34M-1.82M-9.55M
EBITDA Margin Growth (3y)
6.99M-0.04M-0.23M-0.20M-2.05M3.46M
EBITDA Margin (QoQ)
7.14M0.24M-0.02M-0.14M-13.14M13.13M0.05M0.05M-0.81M0.68M-0.38M0.18M0.10M0.06M0.00M-1.98M-7.63M
EBIT Margin Growth (1y)
7.50M-13.27M-0.17M-0.09M0.10M12.65M-0.02M-0.46M-0.33M0.58M-0.04M0.34M-1.86M-9.62M
EBIT Margin Growth (3y)
7.28M-0.04M-0.23M-0.21M-2.08M3.61M
EBIT Margin (QoQ)
7.41M0.25M-0.02M-0.14M-13.36M13.36M0.06M0.05M-0.82M0.69M-0.38M0.18M0.09M0.06M820.00-2.01M-7.67M
EBT Margin Growth (1y)
7.49M-12.43M-0.14M-0.07M0.12M11.89M-0.03M-0.46M-0.32M0.51M-0.05M0.40M-1.78M-9.40M
EBT Margin Growth (3y)
7.29M-0.02M-0.21M-0.13M-1.98M3.00M
EBT Margin (QoQ)
7.39M0.25M-0.02M-0.14M-12.52M12.53M0.06M0.05M-0.75M0.62M-0.38M0.20M0.08M0.06M0.06M-1.99M-7.53M
FCF Margin Growth (1y)
7.43M-10.63M-0.13M-0.15M0.04M9.72M-0.07M-0.02M-0.57M0.82M-0.02M-0.02M-2.11M-8.26M
FCF Margin Growth (3y)
6.90M-0.08M-0.23M-0.20M-2.64M2.28M
FCF Margin (QoQ)
7.28M0.20M0.09M-0.14M-10.78M10.70M0.07M0.05M-1.10M0.90M0.13M-0.50M0.29M0.06M0.12M-2.58M-5.86M
Net Margin Growth (1y)
7.49M-12.46M-0.14M-0.07M0.12M11.92M-0.03M-0.46M-0.32M0.51M-0.05M0.40M-1.78M-9.40M
Net Margin Growth (3y)
7.29M-0.02M-0.21M-0.13M-1.98M3.03M
Net Margin (QoQ)
7.39M0.25M-0.02M-0.14M-12.55M12.56M0.06M0.05M-0.75M0.62M-0.38M0.20M0.08M0.06M0.06M-1.99M-7.54M
Operating Margin Growth (1y)
7.50M-13.27M-0.17M-0.09M0.10M12.65M-0.02M-0.46M-0.33M0.58M-0.04M0.34M-1.86M-9.62M
Operating Margin Growth (3y)
7.28M-0.04M-0.23M-0.21M-2.08M3.61M
Operating Margin (QoQ)
7.41M0.25M-0.02M-0.14M-13.36M13.36M0.06M0.05M-0.82M0.69M-0.38M0.18M0.09M0.06M820.00-2.01M-7.67M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M-0.00M-0.00M-0.00M-0.01M-0.00M742.000.00M0.00M200.00-633.0054.000.00M-0.00M-0.01M-0.01M-0.01M0.00M0.00M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
234.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.01M-0.00M-0.00M-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-711.00-972.00-810.00-0.00M-0.00M0.00M0.00M-436.00-0.00M304.00529.00252.00-85.00-0.00M-0.00M-0.00M-89.000.01M289.00-402.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M-0.00M-0.00M-0.01M-0.01M-0.00M0.00M0.00M0.01M-132.00-0.00M-377.000.00M-0.00M-0.01M-0.01M-0.01M0.00M0.01M0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
520.00-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-7.00-0.00M-0.00M-0.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.01M-0.01M-0.01M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-743.00-0.00M-0.00M-0.00M-0.01M0.01M0.00M-687.00-0.00M360.00336.00340.0048.00-0.00M-0.00M-0.00M-299.000.01M459.00-0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.00M-0.01M-0.01M-0.00M0.00M0.00M0.01M476.00-0.00M-866.00-134.00-0.01M-0.03M-0.05M-0.09M-0.12M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.00M-0.00M-0.00M-0.01M-0.03M-0.05M-0.09M-0.13M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-771.00-0.00M-0.00M-0.00M-0.01M0.01M0.00M-873.00-0.00M727.00637.00-464.00-0.00M-0.01M-0.02M-0.02M-0.04M-0.04M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
7.50M-13.27M-0.17M-0.09M0.10M12.65M-0.02M-0.46M-0.33M0.58M-0.04M0.34M-1.86M-9.62M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
7.28M-0.04M-0.23M-0.21M-2.08M3.61M
Return on Sales [ROS] (QoQ)ROS (QoQ)
7.41M0.25M-0.02M-0.14M-13.36M13.36M0.06M0.05M-0.82M0.69M-0.38M0.18M0.09M0.06M820.00-2.01M-7.67M

Lyra Therapeutics Growth Metrics API

Pull Lyra Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LYRA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY